Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Three-dimensional ultra-structures of myelin and the axons in the spinal cord: Application of SEM with the osmium maceration method to the central nervous system in two mouse models.
Advanced magnetic resonance imaging in pediatric multiple sclerosis.
CSF oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald Criteria 2010: No.
Epstein-Barr virus neuraxis infection as a trigger for central nervous system demyelinating processes: a case report.
Serum antibodies to 25 myelin oligodendrocyte glycoprotein epitopes in multiple sclerosis and neuromyelitis optica: clinical value for diagnosis and disease activity.
Fingolimod and multiple sclerosis: Four cautionary tales.
Cerebrospinal Fluid IL-21 Levels in Neuromyelitis Optica and Multiple Sclerosis.
CD4+ T cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm.
Will Biomarkers Determine What Is Next in Multiple Sclerosis?: Biomarkers in Multiple Sclerosis.
Management of multiple sclerosis in adolescents - current treatment options and related adherence issues.
Regulation of Experimental Autoimmune Encephalomyelitis by TPL-2 Kinase.
Participation of interleukin 17A in neuroimmune interactions.
Vitamin D Therapy in Experimental Allergic Encephalomyelitis Could be Limited by Opposing Effects of Sphingosine 1-Phosphate and Gelsolin Dysregulation.
Contribution of Functional LILRA3, but Not Nonfunctional LILRA3, to Sex Bias in Susceptibility and Severity of Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis.
Sex Disparities in Neuro-Ophthalmologic Disorders.
Sphingolipids: important players in multiple sclerosis.
[Acute disseminated encephalomyelitis (ADEM): its diagnostic criteria and therapy].
SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis.
Comparison of the Effect of 8 weeks Aerobic and Yoga Training on Ambulatory Function, Fatigue and Mood Status in MS Patients.
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab.
Recombinant human PDCD5 (rhPDCD5) protein is protective in a mouse model of multiple sclerosis.
Natalizumab as a Disease-Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy - A Report of Three Cases.
Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis.
JNK inhibitors as anti-inflammatory and neuroprotective agents.
Thalamic Atrophy is Associated with Development of Clinically Definite Multiple Sclerosis.

Pages